Diabetes & CV Disease

Sort by:
Relevance Thumbs Up Comments Views Newest Oldest
21:59

Melinda Maryniuk

2021 ADA Highlights: Diabetes Diets Since the Discovery of Insulin: 1921-1970's Starvation Diets to Exchange System

  • 184 views
  • July 16, 2021
  • 2
07:26

Complex Coronary Cases

Revascularization in Patients with SIHD, Multivessel CAD, ACS and LM Disease: PCI or CABG?

FEATURING Jennifer S. Lawton
  • 314 views
  • July 14, 2021
  • 2
41:15

Jane Reusch

2021 ADA General Highlights: GRADE Study, GIP/GLP-1 Receptor Agonists, Mental Health + Population Considerations in Diabetes, and More

FEATURING Cecilia Low Wang
  • 192 views
  • July 14, 2021
  • 1
11:24

Francesco Giorgino

2021 ADA Highlights: SURPASS Program: Change in HbA1C From Baseline

  • 906 views
  • July 14, 2021
  • 4
16:44

Francesco Giorgino

2021 ADA Highlights: SURPASS-3: Tirzepatide or Basal Insulin Degludec as Injectible Treatment After Oral Antihyperglycemic Medication

  • 702 views
  • July 14, 2021
25:23

Hope Warshaw

2021 ADA Highlights: Diabetes Diets From the 1980's to 2021: Prescribed Macronutrient Percentages to Person-Centered Approaches and Beyond

  • 146 views
  • July 14, 2021
18:47

Becky Sulik

2021 ADA Highlights: Real-World Perspective on Carbohydrate Counting for Bolus Insulin Decision-Making

  • 901 views
  • July 14, 2021
  • 5
16:15

Paul Franks

2021 ADA Highlights: Debate on Precision Nutrition - Take Home Messages

  • 140 views
  • July 14, 2021
12:37

David Wheeler

2021 ADA Highlights: Landmark DAPA-CKD Trial in Kidney Disease: Extending the Benefits of SGLT2 Inhibitors to and Beyond Diabetic Neuropathy

  • 370 views
  • July 14, 2021
  • 4
15:30

Eliot Brinton

2021 ADA Highlights: Substantial Cardiovascular Risk Reduction With Icosapent Ethyl Regardless of BMI or Diabetes Status - REDUCE-IT BMI

  • 793 views
  • July 14, 2021
  • 1
18:17

Brendon Neuen

2021 ADA Highlights: CREDENCE Trial: Lessons Learned From the First Trial in Nearly Two Decades in Regard to Improving Cardiorenal Outcomes in Diabetic Kidney Disease

  • 787 views
  • July 14, 2021
  • 4
08:03

Jennifer Green

Highlights From ADA 2021: The Pros and Cons of Starting SGLT2 Inhibitors or GLP1-RAs in the Hospital to Reduce the Risk of Adverse CV or Kidney Outcomes

  • 359 views
  • July 14, 2021
  • 3
12:10

Hertzel Gerstein

AMPLITUDE: A GLP-1 Receptor Agonist CV Outcomes Trial

  • 225 views
  • July 14, 2021
  • 1
16:05

Piedmont Heart Institute

Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women

FEATURING Denise Reedus, Barbara Conlon
  • 42 views
  • July 13, 2021
21:12

National Lipid Association

Health Disparities Within the Diverse Hispanic Population: Underlying Causes for Health Disparities and Prevention Strategies

FEATURING Eduardo Sanchez
  • 29 views
  • July 9, 2021
18:00

Scripps Health

New Developments in Treatment of Heart Failure With Low EF and Pulmonary HTN: Sacubitril/Valsartan, SGLT-2i, PDE5i and Others

FEATURING Thomas Heywood
  • 314 views
  • July 8, 2021
  • 1
30:46

Scripps Health

Diabetes Treatment in Patients With CVD and HF in 2021: SGLT-2 Inhibitors, GLP1-Receptor Agonists and Other Emerging Therapies

FEATURING Daniel Einhorn
  • 238 views
  • July 7, 2021
  • 2
67:29

Philips

PAD and CLI State of the Art: What Is the Role of Telemedicine? How to Improve Patients' QoL?

FEATURING Chris Lesar, Craig Walker, Sreekumar Madassery, Timothy Yates
  • 344 views
  • July 7, 2021
  • 2
83:52

Philips

Diagnosis and Management of CLI: How to Build Multidisciplinary Care Teams to Treat Diabetic Foot Ulcers and Prevent Amputations?

FEATURING Joseph Griffin, Jason Mendivil, lorena henderson, Fadi Saab
  • 232 views
  • July 6, 2021
43:07

Cardiometabolic Health Congress (CMHC)

Sleep Disorders and Type 2 Diabetes: How Can Sleep Deprivation, Insomnia, Apnea and Excessive Daytime Sleepiness Increase the Risk of T2DM?

FEATURING Naresh M Punjabi
  • 912 views
  • June 29, 2021
  • 2
38:00

Cardiometabolic Health Congress (CMHC)

Discussion: Sleep Disorders and Effect on CVD Risk

FEATURING Virend Somers, Naresh M Punjabi, Eve Van Cauter, Reena Mehra
  • 15 views
  • June 29, 2021
18:05

Jens Juul Holst

GIP Antagonism or Agonism?

  • 49 views
  • June 16, 2021
  • 1
26:29

Charleston HFpEF Virtual Conference: The Latest Knowledge on Heart Failure with preserved Ejection Fraction

Obesity and Weight Management in HFpEF: How Effective and Safe Are Weight-Loss Drugs?

FEATURING Sheldon Litwin
  • 557 views
  • June 15, 2021
  • 6
10:21

Inova Cherry Blossom Virtual Cardiovascular Symposium 2021

The Dangerous Intersection of Diabetes and Heart Disease

FEATURING Darren K. Mcguire
  • 76 views
  • June 8, 2021
12:23

Rita Jermyn

2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of HF Treatment: Answers to 10 Pivotal Issues About HFrEF

  • 1,028 views
  • May 26, 2021
  • 11

Diabetes & CV Disease

All Topics: